• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Nonalcoholic Steatohepatitis
Tags
  • Nonalcoholic Steatohepatitis (NASH)
Study title Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
Disease or condition NASH
Study type Interventional  (Clinical Trial)
Intervention/treatment Lisinopril, open label
Phase 2
Study site Duke University
Study location Durham
Principal investigator name and email Cynthia Moylan, MD
Study coordinator name and email Magdi Elgasim, magdi.elgasim@duke.edu
Phone contact 919-684-9019
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04550481

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE